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Abstract 
Simple accurate and precise Spectrophotometric methods have been developed for simultaneous 
estimation of Simvastatin (SIM) and Sitagliptin (SITA) by employing three methods. Method A was 
simultaneous equation method; the method involves formation and solving the simultaneous equation 
using 238 nm and 267 nm as two wavelengths for SIM and SITA respectively. Method B was first 
order derivative spectrophotometry. The first order derivative absorption at 230 nm (zero crossing 
point of SITA) was used for SIM and 275nm (zero crossing point of SIM) was used for SITA. Method 
C involved Q-absorption analysis based on the measurement of absorbance at two wave lengths that is 
the λmax of SITA 267 nm and isoabsorptive point of both drugs at 250 nm. The three methods obeyed 
the Beer’s law in the concentration range of 3-15 µg/ml for SIM and 50-150 µg/ml for SITA. The 
methods were validated statistically and recovery studies were carried out to confirm the accuracy of 
the method. 
Keywords: Simvastatin, Sitagliptin, Simultaneous Equation Method, First Derivative 
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1. Introduction 
1.1. Sitagliptin: SITA is the first of a new class 
of drugs for the treatment of type two diabetes , 
chemically it is known as (R) -4-oxo – 4- [3-
(triflouromethyl) -5,6- dihydro [1,2,4]triazolo 
[4,3-a]pyrizine -7(8H)-yl ]-1-(2,4,5-trifloro 
phenyl )butan-2-amine.It reduces blood glucose 
concentrations by enhancing the effect of 
incretins. Incretins are harmones (chemicals) 
which are produced by the (bowel) in response 
to food. These drugs are therefore also known as 
incretin enhancers. SITA can be estimated by 
different analytical and bio-analytical 
techniques, they are first order derivative1, 
simultaneous estimation2, UPLC3, 
Spectrophotometry4,5, bio-analytical6, mass 
spectrometry7, spectrofluorimetry8. 
1.2. Simvastatin: SIM belongs to a class of 
drugs called HMG-coA reductase inhibitors 
commonly called statins. It is chemically known 
as (1S, 3R, 7S, 8S, 8aR)-8-{2-[(2r, 4r)-4-
hydroxy-6-oxotetrahydro-2H-pyran-2yl] ethyl}-
3, 7-dimethyl-1, 2, 3, 7, 8.8a-
hexahydronaphthalen-1-yl2, 2-dimethyl 
butanoate. All statins act by inhibiting 3-
hydroxy-3-methylglutaryl coenzyme A HMG-
CoA reductase, the rate limiting enzyme of the 
HMG-CoA reductase path way, the metabolic 
path way responsible  for the endogenous 
production of cholesterol mainly used for the 
treatment of  dislipidimia and the prevention of  
cardiovascular diseases . SIM can be estimated 
by different analytical techniques, they are RP-
HPLC9,10,11,12, derivative Spectrophotometry13, 
spectrophotometry14,15, second order 
derivative16, LC-MS/MS17. 
 
2. Experimental  
2.1. Materials (Instrumentation): LABINDIA 
UV 3092 UV- Visible double beam 
spectrophotometer with a fixed slit width 1 nm 
and 1 cm matched quartz cells was used for all 
the spectral measurements  
2.2. Reagents:  Analytical grade Alcohol, 
distilled water. 
2.3. Preparation of   standard stock solutions: 
A standard SIM stock solution (100µg/ml): 
Standard SIM (10 mg) was dissolved in 10 ml of 
alcohol. The solution was further diluted with 
water to obtain 100 µg/ml. 
Standard stock solution SITA solution 
(100µg/ml): Standard SITA 10 mg was 
sonicated in 10 ml of alcohol. The solution was 
diluted with water to obtain 100µg/ml. 
2.4 .Sample preparation: 10 tablets were taken 
and accurately weighed and weight equalent to 
10 mg of SIM was taken and dissolved in 10 ml 
of alcohol. 
2.5. Method A 
Simultaneous Equation Method: For selection 
of analytical wavelength for Simultaneous 
Equation Method; standard solutions of SIM 
(100 µg/ml) and SITA (100 µg/ml) were 
scanned in the range of 220 to 400 nm. Fig  C 




represents the overlain spectrum of both drugs 
.Wavelengths 238 and 267 nm i.e. the λmax of 
SIM and SITA respectively for the simultaneous 
equation (fig A & B). All the solutions were 
measured at both the wavelengths 238 and 
267nm respectively. Absorptivites at each 
wavelength for SIM and SITA were determined 
and used to form the equation, the absorbance 
and the absorptivites values at particular 
wavelengths were submitted in the following 
equation to obtain the concentration. 
Cx = (A2ay1-A1ay2)/ (ax2ay1-ax1ay2) 
CY = (A1ax2-A2ax1)/ (ax2ay1-ax1ay2) 
CX = concentration of SIM  
CY = concentration of SITA 
A1=absorbance of samples at 238 nm. 
A2= absorbance of samples at 267 nm. 
ax1 is the absorbivity of SIM at 238nm. 
ax2 is the absorbivity of SIM at 267 nm. 
ay1 is the absorbivity of   SITA at 238 nm. 
ay2 is the absorbivity of SITA at 267 nm. 
2.6. Method B: Standard stock solutions (100 
µg/ml) of SIM and SITA were prepared 
separately with water to obtain concentration 
range of 3-15µg/ml for SIM and 50-150µg/ml 
for SITA. For all solutions the derivative spectra 
were obtained over 220-400 nm range. From the 
overlain spectrum of both the drugs (Fig.1) 
wavelengths were selected. At 230 nm there 
were well developed  first order derivative 
absorption spectra for varying concentrations of  
SIM for its determinations (fig.2) and no 
interference was observed by SITA as D1=0 
(fig.2a) so any change in SITA concentration 
has no effect on quantitative determination of 
SIM .  
To determine sita the first order derivative 
spectra were used by making measurement at 
275 nm (fig3) at which D1 =0 for SIM. NO SIM 
interference was found even at different 
concentrations (fig3a) for quantitative 
determination of SITA. The calibration curves 
were constructed by plotting drug concentration 
versus absorbance values of first derivative 
spectrum (D1) 230 nm for SIM and 275 nm for 
SITA .Statistical data for calibration curve is 
depicted in (Table 1). The concentration of 
individual drugs present in the mixture (Fig 4) 
was determined from the calibration curve in 
quantization method. 
2.7. Method C: Absorbance Ratio method: The 
working standard stock solutions of SIM and 
SITA were scanned in the range of 220-400 nm 
against water as blank.  Isoabsorptivity point 
was found at 250 nm (Fig C) and another 
wavelength used was 267 nm which is λmax of 
SITA calibration curve was plotted over a 
concentration range of 3-15µg/ml for SIM and 
50-150 µg/ml for SITA. The absorbance of each 
solution was measured at both the wavelengths 
250nm and 267 nm. Concentrations of SIM and 
SITA were determined using the following 
simultaneous equation. 
CX = (QM-QY)*A1/ (QX-QY)*aX1 
CY=A1/ax1-CX 
Where A1  and A2  are absorbance’s of the 
mixture at 250 nm and 267 nm respectively;ax1 
and ay1  are absorptivites of  SIM  and SITA 
respectively at 250 nm and ax2 and ay2 are 
absorptivites of SIM and SITA respectively at 
267 nm ; 
QM = A2/A1, QX=AX2/AX1 AND 
QY=AY2/AY1. 
 
3. Results and Discussion 
3.1. Validation: 
3.1. A .Linearity range: Calibration curves 
constructed were linear over the selected range 
of 3-15 µg/ml and 50-150µg/ml for SIM and 
SITA respectively. Each concentration was 
repeated three times. The assays were performed 
according to experimental conditions and the 
linearity of the calibration graphs were validated 
by the high value of the correlation coefficient 
and the intercept value. 
3.1. B. Accuracy: Accuracy of the methods was 
assured by standard addition technique involving 
analysis of samples to which certain amounts of 
authentic drugs were added. The resulting 
mixtures were assayed and compared with those 
expected. Recovery studies were given in (Table 
2). 
3.1. C. Precision: For evaluations of precision 
repeatability of the results were evaluated by 6 
replicate determinations .The coefficient of 
variations (%CV) values at these concentration 
levels were calculated. 
3.1. D.Limit of Detection & Limit of 
Quantification: Limit of detection for SIM and 
SITA were found to be 0.121µg/ml,0.213µg/ml 
and 0.314µg/ml. Limit of quantification for SIM 
and SITA were found to be 
0.265µg/ml,0.456µg/ml,0.654µg/ml. 
3.1. E.Application to the pharmaceutical 
dosage form: The proposed methods were 
validated successfully to determine SIM and 
SITA in tablets. No interference of excipients 
were made, therefore the proposed methods 
were employed for simultaneous estimation of 
SIM and SITA. 





The proposed methods are simple accurate and 
precise to determine the quantitative estimation 
of SIM and SITA. 
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Fig A. spectrum of SIM at 238 nm. 
 
Fig B. spectrum of SITA at 267 nm 
 
Fig C: overlain spectra of SIM and SITA 
showing iso-absorptive point at 275 nm 
 
Fig 1: First order derivative overlain spectra 
of SIM   (SIM, 6 µg/ml) and SITA (SITA 75 
µg/ml) 
 
Fig 2: First order derivative spectra for SIM 
(3, 6, 9, 12and 15 µg/ml) at 275 nm 
 
Fig 2a: First order derivative spectra for 
SITA (75 µg/ml) and SIM (3, 6, 9, 12and 15 
µg/ml) 
 
Fig 3: First order derivative spectra for SITA 
(50, 75, 100, 125 and 150µg/ml) at 230 nm 
 




Fig 3b: First order derivative spectra for SIM 







Fig 4: First order derivative spectra of (a) 50, 
(b) 75, (c) 100, (d) 125 and (e) 150 µg/ml  
solution of SITA and (v) 3,  (w) 6, (x)9, (y) 12, 




Table 1: optical and regression characteristics and validation parameters of SIM and SITA 
Parameters SIM SITA 




Method A Method 
B 
Method 
C 238 267 238 267 
Beers law limit   
(µg/ml) 3-15 3-15 3-15 3-15 3-15 3-15 3-15 3-15 
Regression 



















Slope (m) 0.048 0.001 0.002 0.023 0.004 0.001 -0.002 0.001 
Correlation 
coefficient(R2) 0.997 0.996 0.994 0.998 0.996 0.999 0.996 0.996 
Relative standard 
deviation(%RSD)  0.412 0.514 0.513 0.613 0.313 0.368 1.20 1.41 
Precision  
Intraday(n=5) 
(%CV) 0.121 0.132 0.714 1.120 0.214 0.141 0.821 0.912 
Interday(n=5) 
(%CV) 0.241 0.262 0.825 0.320 0.514 0.331 1.12 1.32 
 
Table 2.Results of recovery studies 
Recovery level (%) 
Amount spiked 
(µg/ml) 
Amount  recovered 
(µg/ml) % Mean 
SIM SITA SIM SITA SIM SITA 
Method A 
80 
100 
120 
 
7.2 
9 
10.8 
 
80 
100 
120 
 
7.19 
9.09 
10.807 
 
80.10 
100.05 
119.90 
 
99.86 
101 
100.60 
 
100.125 
100.05 
99.91 
Method B 
80 
100 
120 
 
7.2 
9 
10.8 
 
80 
100 
120 
 
7.205 
8.98 
10.79 
 
79.59 
100.50 
120.05 
 
100.06 
99.77 
99.90 
 
99.48 
100.50 
100.04 
Method C 
80 
100 
120 
 
7.2 
9 
10.8 
 
80 
100 
120 
 
7.18 
8.96 
10.76 
 
79.89 
99.89 
120.20 
 
99.72 
99.55 
99.62 
 
99.86 
99.89 
100.16 
 
